News | September 23, 2023
Lupin acquires five brands from Menarini
Lupin has been exclusively marketing these brands in the Indian market since July 2021
Lupin has been exclusively marketing these brands in the Indian market since July 2021
The complexity of operating on a one-year-old are many with the organs being tiny, fragile
Free Treatment, investigations and sex change surgery along with other facilities will be available at these OPDs for the Transgender community
The state-of-the-art digital PETCT imaging system, highlights a significant advancement in the fight against cancer and detects other lesions offering patient centric services
The 100 surgeries conducted using robotic technology span various intricate procedures in the fields of Urology, Liver Transplantation, GI surgery, Cardiac surgeries and Gynaecology
Investigational cellular therapy, bemdaneprocel (BRT-DA01), was well tolerated with no major safety issues in all 12 participants in low dose and high dose cohorts through one year / At one-year
First PARP inhibitor approved in Japan to demonstrate clinically meaningful benefits in combination with a new hormonal agent
To equip them with the latest knowledge and skills to handle patients coming to them in a better way
SMPA's diverse portfolio includes six marketed products and a robust pipeline of early- to late-stage assets
Decisions on the marketing authorization for Rystiggo in the European and Japanese markets are expected in Q1 of 2024
Subscribe To Our Newsletter & Stay Updated
